Vibativ (Theravance Biopharma R&D, Inc.)


Welcome to the PulseAid listing for the Vibativ drug offered from Theravance Biopharma R&D, Inc.. This Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Theravance Biopharma R&D, Inc.
NON-PROPRIETARY NAME: telavancin hydrochloride
SUBSTANCE NAME: TELAVANCIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-11-05
END MARKETING DATE: 0000-00-00


Vibativ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVibativ from Theravance Biopharma R&D, Inc.
LABELER NAME: Theravance Biopharma R&D, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/mL)
START MARKETING DATE: 2009-11-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62847-001_3acb805d-4fe0-4f56-9c7d-a4c2bd9eb8aa
PRODUCT NDC: 62847-001
APPLICATION NUMBER: NDA022110

Other TELAVANCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Theravance Biopharma R&D, Inc.Vibativ
Theravance, Inc.Vibativ